Trial Profile
The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- 17 Sep 2015 Status changed from recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov.
- 03 Oct 2011 Actual initiation date (Oct 2011) added as reported by ClinicalTrials.gov.
- 03 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.